Nolen WA - Search Results

1

Haloperidol dose when used as active comparator in randomized controlled trials with atypical antipsychotics in schizophrenia: comparison with officially recommended doses.

Hugenholtz GW, Heerdink ER, Stolker JJ, Meijer WE, Egberts AC, Nolen WA. Hugenholtz GW, et al. Among authors: nolen wa. J Clin Psychiatry. 2006 Jun;67(6):897-903. doi: 10.4088/jcp.v67n0606. J Clin Psychiatry. 2006. PMID: 16848649 Review.

2

Short-acting parenteral antipsychotics drive choice for classical versus atypical agents.

Hugenholtz GW, Stolker JJ, Heerdink ER, Nolen WA, Leufkens HG. Hugenholtz GW, et al. Among authors: nolen wa. Eur J Clin Pharmacol. 2003 Mar;58(11):757-60. doi: 10.1007/s00228-002-0545-3. Epub 2003 Feb 13. Eur J Clin Pharmacol. 2003. PMID: 12634982

3

Less medication switching after initial start with atypical antipsychotics.

Hugenholtz GW, Heerdink ER, Nolen WA, Egberts AC. Hugenholtz GW, et al. Among authors: nolen wa. Eur Neuropsychopharmacol. 2004 Jan;14(1):1-5. doi: 10.1016/s0924-977x(03)00043-9. Eur Neuropsychopharmacol. 2004. PMID: 14659981

4

Risk of hip/femur fractures in patients using antipsychotics.

Hugenholtz GW, Heerdink ER, van Staa TP, Nolen WA, Egberts AC. Hugenholtz GW, et al. Among authors: nolen wa. Bone. 2005 Dec;37(6):864-70. doi: 10.1016/j.bone.2005.07.005. Epub 2005 Aug 19. Bone. 2005. PMID: 16111927

5

Incidence and determinants of long-term use of antidepressants.

Meijer WE, Heerdink ER, Leufkens HG, Herings RM, Egberts AC, Nolen WA. Meijer WE, et al. Among authors: nolen wa. Eur J Clin Pharmacol. 2004 Mar;60(1):57-61. doi: 10.1007/s00228-004-0726-3. Epub 2004 Feb 19. Eur J Clin Pharmacol. 2004. PMID: 14985889

6

Changes in outpatient lithium treatment in the Netherlands during 1996-2005.

Wilting I, Souverein PC, Nolen WA, Egberts AC, Heerdink ER. Wilting I, et al. Among authors: nolen wa. J Affect Disord. 2008 Nov;111(1):94-9. doi: 10.1016/j.jad.2008.01.019. Epub 2008 Mar 14. J Affect Disord. 2008. PMID: 18342951

7

Determinants of multiple psychotropic drug use in patients with mild intellectual disabilities or borderline intellectual functioning and psychiatric or behavioral disorders.

Stolker JJ, Heerdink ER, Leufkens HG, Clerkx MG, Nolen WA. Stolker JJ, et al. Among authors: nolen wa. Gen Hosp Psychiatry. 2001 Nov-Dec;23(6):345-9. doi: 10.1016/s0163-8343(01)00164-5. Gen Hosp Psychiatry. 2001. PMID: 11738466

8

Psychotropic drug use in intellectually disabled group-home residents with behavioural problems.

Stolker JJ, Koedoot PJ, Heerdink ER, Leufkens HG, Nolen WA. Stolker JJ, et al. Among authors: nolen wa. Pharmacopsychiatry. 2002 Jan;35(1):19-23. doi: 10.1055/s-2002-19838. Pharmacopsychiatry. 2002. PMID: 11819154

9

[Seclusion of admitted psychotic patients: later in the case of antipsychotic use and also possibly less often].

Stolker JJ, Hugenholtz GW, Heerdink ER, Nijman HL, Leufkens HG, Nolen WA. Stolker JJ, et al. Among authors: nolen wa. Ned Tijdschr Geneeskd. 2003 Mar 22;147(12):557-61. Ned Tijdschr Geneeskd. 2003. PMID: 12693086 Dutch.

10

Reasons for switching between antipsychotics in daily clinical practice.

Hugenholtz GW, Heerdink ER, Meijer WE, Stolker JJ, Egberts AC, Nolen WA. Hugenholtz GW, et al. Among authors: nolen wa. Pharmacopsychiatry. 2005 May;38(3):122-4. doi: 10.1055/s-2005-864122. Pharmacopsychiatry. 2005. PMID: 15902582 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

402 results

Search Page

Filters